Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
Expires | Type | Strike | OI | Change | Percent |
---|---|---|---|---|---|
01/10/2025 | PUT | $84.00 | 5,424 | +4,655 | +605.33% |
01/10/2025 | PUT | $85.00 | 1,586 | +1,027 | +183.72% |
01/10/2025 | PUT | $88.00 | 2,173 | +771 | +54.99% |
03/21/2025 | PUT | $85.00 | 3,015 | +615 | +25.63% |
02/21/2025 | PUT | $80.00 | 1,175 | +343 | +41.23% |
01/16/2026 | PUT | $77.50 | 434 | +300 | +223.88% |
03/21/2025 | CALL | $105.00 | 2,276 | -54 | -2.32% |
01/10/2025 | CALL | $90.00 | 2,460 | -63 | -2.50% |
01/17/2025 | CALL | $100.00 | 4,598 | -67 | -1.44% |
01/17/2025 | PUT | $95.00 | 10,932 | -113 | -1.02% |
01/17/2025 | PUT | $82.50 | 1,182 | -116 | -8.94% |
01/17/2025 | CALL | $90.00 | 2,689 | -285 | -9.58% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
Name | Pct Held | Shares | Total |
---|---|---|---|
Harbor Capital Appreciation Fund | 0.18% | 3.11M | 481.53M |
Washington Mutual Investors Fund | 0.09% | 1.51M | 234.45M |
Vanguard U.S. Growth Fund | 0.07% | 1.27M | 196.47M |
Loomis Sayles Growth Fund | 0.07% | 1.18M | 183.13M |
Fidelity Blue Chip Growth Fund | 0.07% | 1.13M | 175.35M |
Amana Mutual Funds Trust-Growth Fund | 0.06% | 1M | 155.09M |
PGIM Jennison Growth Fd | 0.05% | 828.11k | 128.15M |
Blackrock Equity Dividend Fund | 0.04% | 712k | 110.18M |
New Perspective Fund Inc | 0.04% | 691.44k | 107M |
Price (T.Rowe) International Stock Fund | 0.04% | 674k | 104.3M |
Novo Nordisk Pushes FDA To Exclude Compounding For Its Early-Generation Diabetes Drug
01/06 09:00 am
Benzinga
Read moreIs Novo Nordisk an Undervalued Stock to Buy Now?
01/06 05:30 am
The Motley Fool
Read moreWhat's Going on With Novo Nordisk Stock?
01/05 06:23 am
The Motley Fool
Read moreBetter Buy: Novo Nordisk vs. AstraZeneca
01/04 06:42 am
The Motley Fool
Read more4 Top Stocks to Buy in January
01/02 11:30 am
The Motley Fool
Read moreShould You Buy the Dip in Novo Nordisk Stock Right Now?
01/02 09:30 am
The Motley Fool
Read moreWhy 2024 Was Great for Stocks—and Why 2025 Could Be Even Better
01/02 06:04 am
Investing.com
Read moreVeru Announces the Sale of the FC2 Female Condom® (Internal Condom) Business
12/31 09:30 am
GlobeNewswire Inc.
Read more3 Stocks That Could Be Monster Winners in 2025
12/29 07:47 am
The Motley Fool
Read moreBillionaire Philippe Laffont Is Selling Artificial Intelligence Champion Nvidia and Piling Into These Two Industry Leaders
12/29 06:39 am
The Motley Fool
Read moreIs Eli Lilly Stock a Buy?
12/29 05:35 am
The Motley Fool
Read more10 Top Growth Stocks for 2025
12/28 12:03 pm
The Motley Fool
Read more2 Pharmaceutical Growth Stocks to Buy Now and Hold for Decades
12/28 07:05 am
The Motley Fool
Read moreBetter Buy: Eli Lilly vs. Novo Nordisk. The Answer Is Becoming Abundantly More Clear.
12/26 11:15 am
The Motley Fool
Read moreGlobal Peptide Therapeutics Market to Skyrocket: Estimated Growth at a CAGR of 10.8% to Reach USD 117.4 Billion by 2034: FMI
12/26 09:30 am
GlobeNewswire Inc.
Read moreBetter Buy: Eli Lilly or Novo Nordisk?
12/23 10:30 am
The Motley Fool
Read moreNovo Nordisk, Super Micro Computer And Arm Are Among Top Large Cap Losers Last Week (December 16-20): Are The Others In Your Portfolio?
12/22 11:38 am
Benzinga
Read moreIs Merck the Next Big Weight-Loss Stock?
12/22 07:45 am
The Motley Fool
Read more3 Fantastic Stocks That Could Enjoy a Santa Claus Rally
12/21 07:48 am
The Motley Fool
Read moreIs Now a Good Time to Buy the Dip in Eli Lilly Stock?
12/21 05:55 am
The Motley Fool
Read moreWhat's Going On With Amgen Stock On Friday?
12/20 03:40 pm
Benzinga
Read moreNovo Nordisk A/S: CagriSema demonstrates superior weight loss in adults with obesity or overweight in the REDEFINE 1 trial
12/20 06:41 am
GlobeNewswire Inc.
Read moreThis Is Huge News for Eli Lilly Investors
12/19 05:44 am
The Motley Fool
Read more5 Top European Stocks to Buy Before 2025
12/16 11:48 am
The Motley Fool
Read moreNovo Nordisk invests DKK 8.5 billion in new production facility in Odense, Denmark
12/16 02:29 am
GlobeNewswire Inc.
Read more2 Brand-New Reasons to Buy Eli Lilly Stock Right Now, and 2 Reasons to Be Cautious
12/15 03:05 pm
The Motley Fool
Read moreTelehealth Firm Ro Partners With Eli Lilly to Boost Access to Obesity Drug Zepbound
12/12 10:38 am
Benzinga
Read moreBillionaire Izzy Englander Is Buying This Obesity Drug Stock That Could Soar Nearly 20%, According to Wall Street
12/06 06:47 am
The Motley Fool
Read moreEli Lilly: Breakthrough Trial Results Set Stage for Market Growth, Stock Gains
12/05 06:32 am
Investing.com
Read moreDown 12.3% at One Point in a Single Trading Session, Is Amgen Stock Still a Buy?
11/30 07:20 am
The Motley Fool
Read moreIs Novo Nordisk Stock a Buy?
11/29 06:35 am
The Motley Fool
Read moreIs Amgen Stock Still a Buy After an Unexpected Reveal of Data?
11/29 05:28 am
The Motley Fool
Read moreBiden Proposes Medicare, Medicaid Access For Popular Weight-Loss Drugs
11/26 11:09 am
Benzinga
Read moreIs Novo Nordisk Stock a Buy Right Now?
11/20 07:10 am
The Motley Fool
Read more3 Growth Stocks You Can Buy Right Now Without Any Hesitation
11/18 07:03 am
The Motley Fool
Read more3 Things You Need to Know if You Buy Viking Therapeutics Today
11/18 05:45 am
The Motley Fool
Read more2 Reasons to Buy Amgen Stock, and 1 Reason to Be Cautious
11/16 09:45 am
The Motley Fool
Read morePrediction: Acquisitions Will Skyrocket Under The Trump Administration. Here's 1 Pharmaceutical Company I Have My Eyes On.
11/16 06:30 am
The Motley Fool
Read moreShould You Forget Eli Lilly and Buy This Magnificent Biotech Stock Instead?
11/15 05:05 am
The Motley Fool
Read moreIs AstraZeneca a Buy as It Eyes the Weight Loss Market?
11/14 08:15 am
The Motley Fool
Read more1 Growing Biotech Stock to Buy Today With $1,000 and Hold for 5 Years or More
11/10 10:30 am
The Motley Fool
Read moreIs Viking Therapeutics a Buy on the Dip?
11/10 06:15 am
The Motley Fool
Read moreGot $5,000? Viking Therapeutics Stock Just Got a Big New Green Flag
11/07 11:15 am
The Motley Fool
Read moreNovo Nordisk's sales increased by 23% in Danish kroner and by 24% at constant exchange rates to DKK 204.7 billion in the first nine months of 2024
11/06 02:41 am
GlobeNewswire Inc.
Read moreNovo Nordisk's sales increased by 23% in Danish kroner and by 24% at constant exchange rates to DKK 204.7 billion in the first nine months of 2024
11/06 02:30 am
GlobeNewswire Inc.
Read morePrediabetes Market to hit USD 360.6 million by 2032, says Global Market Insights Inc.
11/05 07:00 am
GlobeNewswire Inc.
Read more